In eye care, treatment outcomes often rely on how soon a drug is accessed and administered, and that’s definitely the case with eye infections. Although keeping meds on hand at your clinic would be ideal, they can be costly to maintain. A new compounded antibiotic from ImprimisRx called Fortisite—which combines tobramycin 1.5% and vancomycin 5%—presents a solution, the company says. As part of the company’s Patient Access Program, ImprimisRx says that it will offer a 100% replacement guarantee for any expired 503B Fortisite product. The formulation can last for up to 180 days when kept refrigerated at a temperature of 5°C, according to a company press release.

The antibiotic is now available for order by patients through the ImprimisRx 503A pharmacy, the company says. Physicians will be able to stock Fortisite in their clinics once it’s available through the ImprimisRx 503B outsourcing facility, which is expected to happen in the first half of 2023.

For more information, visit